PIQ — Proteomics International Laboratories Income Statement
0.000.00%
Last trade - 00:00
- AU$148.03m
- AU$142.98m
- AU$1.47m
- 42
- 11
- 82
- 44
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.52 | 1.61 | 1.47 | 1.72 | 1.47 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3.32 | 3.33 | 4.3 | 6.7 | 7.7 |
Operating Profit | -1.8 | -1.72 | -2.84 | -4.97 | -6.23 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.08 | -1.74 | -2.86 | -4.97 | -6.23 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.08 | -1.74 | -2.86 | -4.97 | -6.23 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -2.08 | -1.74 | -2.86 | -4.97 | -6.18 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.08 | -1.74 | -2.86 | -4.97 | -6.18 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.026 | -0.023 | -0.03 | -0.047 | -0.053 |